Published in Sarcoidosis Vasc Diffuse Lung Dis on March 01, 1999
A Case Controlled Etiologic Study of Sarcoidosis (ACCESS) | NCT00005276
A concise review of pulmonary sarcoidosis. Am J Respir Crit Care Med (2010) 1.98
HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet (2003) 1.57
Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med (2014) 1.04
Overview of neurosarcoidosis: recent advances. J Neurol (2014) 1.02
Advances in the diagnosis and treatment of sarcoidosis. F1000Prime Rep (2014) 0.96
Diagnostic management of patients with suspected ocular sarcoidosis. J Thorac Dis (2013) 0.94
T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells? Clin Exp Immunol (2009) 0.89
Fas promoter polymorphisms: genetic predisposition to sarcoidosis in African-Americans. Tissue Antigens (2008) 0.84
Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients. Ann Thorac Med (2010) 0.84
Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis Protocol. Ann Am Thorac Soc (2015) 0.83
Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans. Am J Respir Cell Mol Biol (2015) 0.83
Comorbid illnesses and chest radiographic severity in African-American sarcoidosis patients. Lung (2007) 0.82
Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis. J Invest Dermatol (2009) 0.80
Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease. Cytokine (2013) 0.79
Acute kidney injury caused by sarcoid granulomatous interstitial nephritis without extrarenal manifestations. CEN Case Rep (2015) 0.78
How many organs need to be involved to diagnose sarcoidosis?: An unanswered question that, hopefully, will become irrelevant. Sarcoidosis Vasc Diffuse Lung Dis (2014) 0.78
Effect of smoking and gender on pulmonary function and clinical features in sarcoidosis. Lung (2012) 0.78
Cardiac Sarcoidosis: Is it More Common in Men? Lung (2015) 0.77
Clinical characteristics and computed tomography findings in Arab patients diagnosed with pulmonary sarcoidosis. Ann Saudi Med (2009) 0.77
The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis. Respir Med (2015) 0.77
Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther (2016) 0.76
Sarcoidosis: yet another masquerader the cardiologist / electrophysiologist has to fight with. Indian Pacing Electrophysiol J (2010) 0.75
Prevalence of cardiac sarcoidosis in white population: a case-control study: Proposal for a novel risk index based on commonly available tests. Medicine (Baltimore) (2016) 0.75
Hyercalcemia induced by interferon therapy in chronic hepatitis C. J Family Community Med (2012) 0.75
Cumulative Incidence and Predictors of Progression in Corticosteroid-Naïve Patients with Sarcoidosis. PLoS One (2015) 0.75
Spinal cord hemorrhage in a patient with neurosarcoidosis on long-term corticosteroid therapy: case report. BMC Neurol (2015) 0.75
Comprehensive evaluation of airway involvement in pulmonary sarcoidosis. ERJ Open Res (2017) 0.75
Prevalence of echocardiographic features suggesting cardiac sarcoidosis in patients with pacemaker or implantable cardiac defibrillator. Korean Circ J (2011) 0.75
Validation of the Japanese version of the Sarcoidosis Health Questionnaire: a cross-sectional study. Health Qual Life Outcomes (2011) 0.75
Sarcoidosis manifesting as hepatic and splenic nodules mimicking ovarian cancer metastases: A case report. Oncol Lett (2015) 0.75
Positron emission tomography imaging in sarcoidosis. World J Nucl Med (2013) 0.75
Multimodality Imaging in Cardiac Sarcoidosis: Is There a Winner? Curr Cardiol Rev (2016) 0.75
Laboratory support in the diagnosis of uveitis. Indian J Ophthalmol (2013) 0.75
[Sarcoidosis : Renal manifestations]. Z Rheumatol (2017) 0.75
FCGR3A and FCGR3B copy number variations are risk factors for sarcoidosis. Hum Genet (2016) 0.75
Assessment of cardiac involvement in sarcoidosis by echocardiography. Rheumatol Int (2009) 0.75
Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain. Medicine (Baltimore) (2017) 0.75
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med (1995) 13.59
Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med (2001) 6.27
Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop. N Engl J Med (1984) 4.46
Quantitative studies of mycobacterial populations in sputum and saliva. Am Rev Respir Dis (1967) 3.00
Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med (1996) 2.88
Single breath diffusing capacity in a representative sample of the population of Michigan, a large industrial state. Predicted values, lower limits of normal, and frequencies of abnormality by smoking history. Am Rev Respir Dis (1983) 2.83
The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV. Chest (1995) 2.65
Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol (1988) 2.60
Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. Blood (1997) 2.55
Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis. J Infect Dis (1995) 2.35
Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation (1991) 2.33
Determination of mycobacterial antigens in sputum by enzyme immunoassay. J Clin Microbiol (1986) 2.27
Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg Infect Dis (2000) 2.08
Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation (2000) 2.07
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J (2008) 1.99
Changes in pulmonary function in workers exposed to vinyl chloride and polyvinyl chloride. Ann N Y Acad Sci (1975) 1.95
Diagnosis and management of neurological sarcoidosis. Arch Intern Med (1997) 1.93
Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Mod Pathol (1996) 1.90
Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Medicine (Baltimore) (1996) 1.90
Mean and instantaneous expiratory flows, FVC and FEV1: prediction equations from a probability sample of Michigan, a large industrial state. Bull Eur Physiopathol Respir (1987) 1.88
Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis (1987) 1.75
Report of ERS Task Force: guidelines for measurement of acellular components and standardization of BAL. Eur Respir J (1999) 1.74
Effects of tetracycline on leukotaxis. J Infect Dis (1974) 1.69
Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med (2001) 1.68
Depression in sarcoidosis. Am J Respir Crit Care Med (2001) 1.67
Asbestos-associated chromosomal changes in human mesothelial cells. Proc Natl Acad Sci U S A (1985) 1.60
Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. Ann Intern Med (1991) 1.58
Pulmonary disease due to Mycobacterium intracellulare. Am Rev Respir Dis (1973) 1.57
Human alveolar macrophages: effects of endotoxin in vitro. Infect Immun (1980) 1.55
A prospective investigation of pulmonary embolism in women and men. JAMA (1992) 1.52
Diagnosis of lung cancer by fibreoptic bronchoscopy: problems in the histological classification of non-small cell carcinomas. Thorax (1984) 1.52
Pulmonary embolism and mortality in patients with COPD. Chest (1996) 1.49
Recovery of viruses other than cytomegalovirus from bronchoalveolar lavage fluid. Chest (1994) 1.48
Effect of an aggressive lipid-lowering strategy on progression of atherosclerosis in the left main coronary artery from patients in the post coronary artery bypass graft trial. Circulation (2001) 1.46
Pulmonary diffusing capacity in left ventricular dysfunction. Chest (1990) 1.46
Effect of obesity on patient-reported outcomes in sarcoidosis. Int J Tuberc Lung Dis (2013) 1.43
A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion (1998) 1.42
Metachronous cancers or late recurrences after resection of stage I lung cancer. Ann Thorac Surg (1999) 1.41
Inhaler and spacer use in obstructive airway diseases. Am Fam Physician (1990) 1.38
Surfactant protein deficiency in familial interstitial lung disease. J Pediatr (2001) 1.37
Geographic clustering of Pneumocystis carinii pneumonia in patients with HIV infection. Am J Respir Crit Care Med (2000) 1.37
Differences in uptake of mycobacteria by human monocytes: a role for complement. Infect Immun (1988) 1.32
Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea. Control Clin Trials (1995) 1.32
Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure. J Infect Dis (1998) 1.30
Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med (1997) 1.28
Talc pneumoconiosis. Significance of sublight microscopic mineral particles. Am J Med (1971) 1.27
Source of Pneumocystis carinii in recurrent episodes of pneumonia in AIDS patients. AIDS (1996) 1.26
Oxygen delivery in critically ill patients. Relationship to blood lactate and survival. Chest (1985) 1.24
Can tuberculosis cause sarcoidosis? New techniques try to answer an old question. Chest (1998) 1.23
Complications and validity of pulmonary angiography in acute pulmonary embolism. Circulation (1992) 1.20
Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Acta Cytol (1998) 1.18
Selection of oligoclonal V beta-specific T cells in the intradermal response to Kveim-Siltzbach reagent in individuals with sarcoidosis. J Immunol (1995) 1.13
A reappraisal of the circulatory effects of the Valsalva maneuver. Am J Med (1965) 1.13
Pinocytosis by human alveolar macrophages. Comparison of smokers and nonsmokers. J Clin Invest (1974) 1.11
Sarcoidosis: analysis of cells obtained by bronchial lavage. Am Rev Respir Dis (1977) 1.10
Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. Am J Hematol (2000) 1.09
Use of the protected specimen brush in patients with endotracheal or tracheostomy tubes. Chest (1987) 1.09
Estimated vs actual values for dead space/tidal volume ratios during incremental exercise in patients evaluated for dyspnea. Chest (1994) 1.09
Alveolar macrophages: depression of protein synthesis during phagocytosis. Am J Physiol (1970) 1.08
The pathogenesis of experimental pulmonary histoplasmosis. Correlative studies of histopathology, bronchoalveolar lavage, and respiratory function. Am Rev Respir Dis (1986) 1.07
Anti-IL-8 autoantibodies in alveolar fluid from patients with the adult respiratory distress syndrome. J Immunol (1996) 1.07
Nonopsonic uptake of Mycobacterium avium complex by human monocytes and alveolar macrophages. J Lab Clin Med (1992) 1.06
Extrapulmonary sarcoidosis. Semin Respir Infect (1998) 1.06
Natural killer cell-mediated lysis of Mycobacterium-avium complex-infected monocytes. J Clin Immunol (1990) 1.06
Quantitation of bronchoalveolar lavage with methylene blue. Am Rev Respir Dis (1983) 1.06
Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun (2005) 1.04
Airway function in chronic pulmonary sarcoidosis with fibrosis. Am Rev Respir Dis (1974) 1.04
Prolonged use of methotrexate for sarcoidosis. Arch Intern Med (1995) 1.03
Diagnosis of pulmonary complications of the acquired immune deficiency syndrome. Thorax (1985) 1.03
Diagnosis of acute pulmonary embolism in the elderly. J Am Coll Cardiol (1991) 1.02
Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: who, what, and how to use them. Sarcoidosis Vasc Diffuse Lung Dis (2008) 1.01
Differentiation of sarcoidosis from tuberculosis using real-time PCR assay for the detection and quantification of Mycobacterium tuberculosis. Sarcoidosis Vasc Diffuse Lung Dis (2008) 1.01
Comparison of gallium-67 scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme levels in pulmonary sarcoidosis. Predicting response to therapy. Am Rev Respir Dis (1984) 1.01
Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med (2001) 1.01
Effect of changing instilled volume for bronchoalveolar lavage in patients with interstitial lung disease. Am Rev Respir Dis (1985) 1.00
Pulmonary function and radiographic changes in 598 workers with varying duration of exposure to asbestos. Mt Sinai J Med (1970) 0.99
Nephrectomy in selected patients with severe refractory hypertension receiving dialysis. Surg Gynecol Obstet (1975) 0.98
Solitary pulmonary nodules due to nontuberculous mycobacterial infection. Am J Med (1981) 0.98
Modulation of mitogen-induced proliferation of autologous peripheral blood lymphocytes by human alveolar macrophages. Infect Immun (1982) 0.98
Comparative production of interferon by explanted lymphoreticular tissue and alveolar macrophages from rabbits and humans. Infect Immun (1976) 0.97
Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group. J Am Coll Cardiol (1995) 0.97
Radioaerosol lung clearance in patients with active pulmonary sarcoidosis. Am Rev Respir Dis (1985) 0.95
Lung sound analysis for continuous evaluation of airflow obstruction in asthma. Chest (1985) 0.94
Tuberculous empyema necessitatis. Computed tomography findings. Clin Imaging (1990) 0.93
Hyaluronan receptor (CD44) expression and function in human peripheral blood monocytes and alveolar macrophages. J Leukoc Biol (1994) 0.93
Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest (1995) 0.93
The anemia of sarcoidosis. Sarcoidosis (1988) 0.92
Quantitation of wheezing in acute asthma. Chest (1984) 0.92
Tracheobronchial secretions. Am J Med (1971) 0.92
Application of the flexible bronchoscope. Mt Sinai J Med (1975) 0.92